(Q30852962)

9 November 2017

Assessing liver injury associated with antimycotics: Concise literature review and clues from data mining of the FAERS database (English)

1 reference

9 November 2017

0 references

1

1 reference

9 November 2017

Elisabetta Poluzzi

2

0 references

Fabrizio De Ponti

object named as

Fabrizio De Ponti

series ordinal

5

0 references

Ariola Koci

series ordinal

3

object named as

Ariola Koci

1 reference

9 November 2017

Paolo Caraceni

4

1 reference

9 November 2017

1 August 2014

1 reference

World Journal of Hepatology

9 November 2017

1 reference

9 November 2017

6

1 reference

9 November 2017

8

1 reference

9 November 2017

601-612

1 reference

Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment

9 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Defining a reference set to support methodological research in drug safety

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

How to avoid being surprised by hepatotoxicity at the final stages of drug development and approval

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Idiosyncratic drug-induced liver injury: an update on the 2007 overview

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Outpatient systemic antimycotic and antifungal use in Europe: new outcome measure provides new insight

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Ketoconazole associated hepatotoxicity: a systematic review and meta- analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Risk of oral antifungal agent-induced liver injury in Taiwanese

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Performance of pharmacovigilance signal-detection algorithms for the FDA adverse event reporting system

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Antipsychotics and torsadogenic risk: signals emerging from the US FDA Adverse Event Reporting System database.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Associations of gender and age with the reporting of drug-induced hepatic failure: data from the VigiBase™.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Current challenges and controversies in drug-induced liver injury.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Latest advances in predicting DILI in human subjects: focus on biomarkers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Antifungal therapy in European hospitals: data from the ESAC point-prevalence surveys 2008 and 2009.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Hepatic safety of antibiotics used in primary care

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Case definition and phenotype standardization in drug-induced liver injury.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Antimicrobials and the risk of torsades de pointes: the contribution from data mining of the US FDA Adverse Event Reporting System

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Important elements for the diagnosis of drug-induced liver injury

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Safety of triazole antifungal drugs in patients with cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Intrinsic versus idiosyncratic drug-induced hepatotoxicity--two villains or one?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Quantitative signal detection using spontaneous ADR reporting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Telithromycin-associated hepatotoxicity: Clinical spectrum and causality assessment of 42 cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year period

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Can pharmacogenetics help rescue drugs withdrawn from the market?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Outcome and prognostic markers in severe drug-induced liver disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Idiosyncratic drug hepatotoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Terbinafine-associated hepatotoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Terbinafine hepatotoxicity: case report and review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Criteria of drug-induced liver disorders. Report of an international consensus meeting

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events

21 June 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: search for signals

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

Terbinafine hepatotoxicity resulting in chronic biliary ductopenia and portal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

Drugs associated with hepatotoxicity and their reporting frequency of liver adverse events in VigiBase: unified list based on international collaborative work.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I8.601

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4163743

High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury

25 November 2018

1 reference

12 December 2020

High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury

1 reference

12 December 2020

Hy's law: predicting serious hepatotoxicity

1 reference

12 December 2020

Drug-induced liver injury

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V6.I8.601

1 reference

9 November 2017

1 reference

9 November 2017

1 reference

PMCID

4163743